Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice.

Essential role for macrophage migration inhibitory factor in gastritis induced by Helicobacter pylori. Am J Pathol (2009) 0.94

Effects of Helicobacter pylori eradication in patients with immune thrombocytopenic purpura. Korean J Hematol (2010) 0.94

Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice. Microb Pathog (2007) 0.90

Structural modifications of Helicobacter pylori lipopolysaccharide: an idea for how to live in peace. World J Gastroenterol (2014) 0.81

Case-control study of association of eosinophilic gastrointestinal disorders with Helicobacter pylori infection in Japan. J Clin Biochem Nutr (2013) 0.79

Adherence and invasion of mouse-adapted H pylori in different epithelial cell lines. World J Gastroenterol (2007) 0.78

Helicobacter pylori vaccination: is there a path to protection? World J Gastroenterol (2014) 0.78

Bioactivity and immunological evaluation of LPS from different serotypes of Helicobacter pylori. Iran J Microbiol (2013) 0.77

Immunological response to parenteral vaccination with recombinant hepatitis B virus surface antigen virus-like particles expressing Helicobacter pylori KatA epitopes in a murine H. pylori challenge model. Clin Vaccine Immunol (2011) 0.76

Lower circulating levels of chemokine CXCL10 in Helicobacter pylori-infected patients with peptic ulcer: Influence of the bacterial virulence factor CagA. Iran J Microbiol (2013) 0.75

Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe (2009) 4.20

Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope. AIDS (2008) 2.06

Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate. J Virol (2003) 2.00

Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant. J Virol (2010) 1.98

Functional plasticity in the type IV secretion system of Helicobacter pylori. PLoS Pathog (2013) 1.84

From bench to bedside: stealth of enteroinvasive pathogens. Nat Rev Microbiol (2008) 1.58

An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector. J Virol (2003) 1.56

Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS One (2010) 1.45

Helicobacter pylori AddAB helicase-nuclease and RecA promote recombination-related DNA repair and survival during stomach colonization. Mol Microbiol (2008) 1.33

Description of 'Candidatus Helicobacter heilmannii' based on DNA sequence analysis of 16S rRNA and urease genes. Int J Syst Evol Microbiol (2004) 1.31

Genotypic profile of the outer membrane proteins BabA and BabB in clinical isolates of Helicobacter pylori. Infect Immun (2006) 1.29

Expression of the BabA adhesin during experimental infection with Helicobacter pylori. Infect Immun (2010) 1.26

Helicobacter pylori induces an antimicrobial response in rhesus macaques in a cag pathogenicity island-dependent manner. Gastroenterology (2008) 1.21

Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile. Clin Infect Dis (2012) 1.11

The role of genome diversity and immune evasion in persistent infection with Helicobacter pylori. FEMS Immunol Med Microbiol (2005) 1.08

Evaluation of Clostridium difficile fecal load and limit of detection during a prospective comparison of two molecular tests, the illumigene C. difficile and Xpert C. difficile/Epi tests. J Clin Microbiol (2012) 1.07

Comparison of Helicobacter pylori virulence gene expression in vitro and in the Rhesus macaque. Infect Immun (2005) 1.06

Captive rhesus monkeys (Macaca mulatta) are commonly infected with Helicobacter cinaedi. J Clin Microbiol (2002) 1.05

Inflammation, immunity, and vaccine development for Helicobacter pylori. Helicobacter (2011) 1.05

Outcomes in patients tested for Clostridium difficile toxins. Diagn Microbiol Infect Dis (2012) 1.03

Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and nonstructural proteins 3, 4, and 5. J Virol (2008) 1.01

Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles. J Virol (2005) 1.00

Modification of gastric mucin oligosaccharide expression in rhesus macaques after infection with Helicobacter pylori. Gastroenterology (2009) 0.99

Gastric transcription profile of Helicobacter pylori infection in the rhesus macaque. Infect Immun (2004) 0.95

All that palsies is not Bell's -the need to define Bell's palsy as an adverse event following immunization. Vaccine (2007) 0.95

Life at the margins: modulation of attachment proteins in Helicobacter pylori. Gut Microbes (2011) 0.93

The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles. J Pharm Sci (2008) 0.92

Transcription profile of Helicobacter pylori in the human stomach reflects its physiology in vivo. J Infect Dis (2004) 0.91

Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice. Microb Pathog (2007) 0.90

Antibody responses against HIV in rhesus macaques following combinations of mucosal and systemic immunizations with chimeric alphavirus-based replicon particles. AIDS Res Hum Retroviruses (2006) 0.90

Dynamics of acute and memory mucosal and systemic immune responses against HIV-1 envelope following immunizations through single or combinations of mucosal and systemic routes. Vaccine (2007) 0.89

A comparison of anionic nanoparticles and microparticles as vaccine delivery systems. Hum Vaccin (2007) 0.89

The impact of Helicobacter pylori infection on the gastric microbiota of the rhesus macaque. PLoS One (2013) 0.88

Serum glycan signatures of gastric cancer. Cancer Prev Res (Phila) (2013) 0.88

Quantitation of H. pylori cytotoxin mRNA by real-time RT-PCR shows a wide expression range that does not correlate with promoter sequences. Microb Pathog (2004) 0.88

A chimeric alphavirus RNA replicon gene-based vaccine for human parainfluenza virus type 3 induces protective immunity against intranasal virus challenge. Vaccine (2006) 0.87

Inhibition of heat shock protein expression by Helicobacter pylori. Microb Pathog (2009) 0.86

In vivo expression of Helicobacter pylori virulence genes in patients with gastritis, ulcer, and gastric cancer. Infect Immun (2011) 0.86

Maintenance of long-term immunological memory by low avidity IgM-secreting cells in bone marrow after mucosal immunizations with cholera toxin adjuvant. Vaccine (2004) 0.86

Novel gastric helicobacters and oral campylobacters are present in captive and wild cetaceans. Vet Microbiol (2011) 0.84

Use of inactivated Escherichia coli enterotoxins to enhance respiratory mucosal adjuvanticity during vaccination in swine. Clin Vaccine Immunol (2011) 0.84

Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations. Infect Immun (2007) 0.84

Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes. Expert Opin Biol Ther (2010) 0.84

Conserved transcriptional unit organization of the cag pathogenicity island among Helicobacter pylori strains. Front Cell Infect Microbiol (2012) 0.84

Beta7-integrin-independent enhancement of mucosal and systemic anti-HIV antibody responses following combined mucosal and systemic gene delivery. Immunology (2007) 0.83

Predicting the outcome of infectious diseases: variability among inbred mice as a new and powerful tool for biomarker discovery. MBio (2012) 0.82

A novel retinoic acid, catechin hydrate and mustard oil-based emulsion for enhanced cytokine and antibody responses against multiple strains of HIV-1 following mucosal and systemic vaccinations. Vaccine (2011) 0.82

Lack of interference with immunogenicity of a chimeric alphavirus replicon particle-based influenza vaccine by preexisting antivector immunity. Clin Vaccine Immunol (2012) 0.78

Environmental determinants of transformation efficiency in Helicobacter pylori. J Bacteriol (2013) 0.78

Prolonged protection against Intranasal challenge with influenza virus following systemic immunization or combinations of mucosal and systemic immunizations with a heat-labile toxin mutant. Clin Vaccine Immunol (2009) 0.77

Method for profiling mucin oligosaccharides from gastric biopsies of rhesus monkeys with and without Helicobacter pylori infection. Anal Chem (2007) 0.76

Maintenance of long-term immunological memory by Ig+CD45R+ non-plasma B cells following mucosal immunizations. Immunol Lett (2011) 0.76

Treatment with moxifloxacin versus standard therapy for community-acquired pneumonia. Clin Infect Dis (2006) 0.75

Apoptosis of gastric lymphocytes in Helicobacter pylori-infected rhesus macaques. Dig Dis Sci (2003) 0.75

Meeting report: a symposium on the evolution of common molecular pathways underlying innate immunity. Microbes Infect (2012) 0.75